Taranjit S. Gujral
Papers
1
Total Citations
6
H-Index
1
About
Taranjit S. Gujral is a pioneering bioengineer whose research lies at the intersection of micro-robotics, tissue engineering, and personalized oncology. His key contributions focus on developing low-cost, high-throughput microtechnologies to overcome the critical scarcity of human biopsies for drug testing. In his landmark 2025 work, "Low-cost robotic manipulation of live microtissues for cancer drug testing" (6 citations), Gujral introduced a novel platform that combines microscale robotic manipulation with microfluidics to precisely position and test live microtissues. This innovation enables the miniaturization of disease models, allowing researchers to perform drug screening on scarce patient-derived samples with unprecedented efficiency and affordability. By reducing the need for large biopsy quantities, his work directly addresses a paramount challenge in developing therapeutics and personalized treatments. Gujral’s contributions are particularly impactful for translational cancer research, where his technology promises to accelerate the discovery of effective drugs tailored to individual patients. His achievements exemplify how creative engineering solutions can bridge the gap between bench science and clinical application, making him a rising leader in the field of microtissue-based drug testing.
Research Focus
Key Achievements
Top Papers
- 1